The Bharat Biotech on Tuesday got emergency use authorisation from the Drugs Controller General of India (DCGI) for the Intranasal Covid-19 vaccine. R...
Tuesday, September 6, 2022 3:39 PM
DCGI (Drugs Controller General of India) gives restricted emergency use authorisation to BharatBiotech's Covaxin for children between the age of 6-12...
Tuesday, April 26, 2022 12:56 PM
The Drugs Controller General of India (DCGI) on Friday granted permission to Bharat Biotech to conduct clinical trials of intranasal vaccine BBV154.
Friday, January 28, 2022 5:10 PM
The Drugs Controller General of India (DCGI) on Thursday granted conditional regular market approval for COVID-19 vaccines Covaxin and Covishield for...
Thursday, January 27, 2022 5:56 PM
Indian vaccine manufacturing company Serum Institute of India (SII) has sought permission from the Drug Controller General of India (DCGI) for the pro...
Thursday, June 3, 2021 5:17 PM
The Drugs Controller General of India (DCGI) has done away with specific trials of COVID-19 vaccines that have been approved by other international re...
Wednesday, June 2, 2021 12:57 PM
Zydus Cadila has sought approval from the Drugs Controller General of India (DCGI) to undertake clinical trials for monoclonal antibodies cocktail tha...
Thursday, May 27, 2021 3:19 PM
The Drugs Controller General of India (DCGI) has approved the emergency use of an anti-COVID drug - 2-deoxy-D-glucose (2-DG) - as an adjunct therapy i...
Saturday, May 8, 2021 5:31 PM
As India gears up for the world's largest vaccination programme, the Drugs Controller General of India (DCGI) on Sunday quelled rumours surrounding th...
Sunday, January 3, 2021 1:14 PM
Prime Minister Narendra Modi congratulated the country as Drugs Controller General of India (DCGI) granted emergency use approval to Serum Institute o...
Sunday, January 3, 2021 12:05 PM
COVID-19 vaccines of Serum Institue of India and Bharat Biotech have been granted permission for restricted use in emergency situation, said Drugs Con...
Sunday, January 3, 2021 11:42 AM
The Serum Institute of India (SII) has applied to the Drugs Controller General of India (DCGI) seeking emergency use authorisation for its COVID-19 va...
Monday, December 7, 2020 10:00 AM
The Drugs Controller General of India (DCGI) gave approval to Serum Institute of India, Pune to conduct Phase II+III clinical trials of Oxford Univers...
Monday, August 3, 2020 7:45 PM
Loading Poll …